Narayana Health’s Banashankari Hospital Goes Fully Paperless
Narayana Health’s 110-bed KS-Narayana Hospital in Banashankari, Bengaluru, runs registration, billing, consent and discharge on WhatsApp with no paper.
Narayana Health’s 110-bed KS-Narayana Hospital in Banashankari, Bengaluru, runs registration, billing, consent and discharge on WhatsApp with no paper.
OneSource Specialty Pharma has received a USFDA EIR with VAI classification for its Bengaluru Sterile Product Division, closing the June 2026 inspection.
Apollo Hospitals, Bannerghatta Road, Bengaluru, is among the first in India to adopt Intuitive’s Da Vinci 5 robotic surgical system, now used across cardiac, oncology, gynaecology, GI and urology surgery.
Fortis Healthcare, through its subsidiary International Hospital Limited, has acquired the 110-bed Suguna Hospital in Rajajinagar, Bengaluru, for about ₹277 crore in an all-cash slump sale, taking its operational beds in the city to around 1,000.
Bengaluru-based NU Hospitals has unveiled the AMS EDGE robotic surgical system, with AI-assisted imaging and telesurgery capability, alongside a new NU App that brings appointments, records, payments and home sample collection onto one platform.
Bengaluru, September 30, 2026: Healthcare AI company Prodoc AI has raised an undisclosed amount in seed funding to strengthen its […]
Alcon has expanded its presence in India with the launch of a second office for Alcon Global Services (AGS) in […]
Kyno Health, a fast-emerging health-tech platform, has launched its pioneering “Doctor at Home in 20 Minutes” service across Delhi-NCR and […]
Imperial College London has launched its Imperial Global India Hub in Bengaluru, aiming to double Indo-UK collaborative research funding to […]
Japan’s Takeda Pharmaceutical Company has taken a significant leap forward in its digital transformation journey by establishing its first Asian […]
CBM India, a prominent organization focused on disability-inclusive development, has taken a significant step towards improving community eye health services […]
AstraZeneca Pharma India Limited, a subsidiary of AstraZeneca Plc, UK, has made a regulatory announcement regarding the proposed sale of […]
The US Food and Drug Administration (FDA) has designated a path breaking cancer-treating device, developed by the Bengaluru-based scientist as […]